Single-cell analysis with spatial resolution further helped them ... More information: David Requena et al, Liver cancer multiomics reveals diverse protein kinase A disruptions convergently produce ...

T-cells from the liver and lymph nodes show promising potential for future treatments of liver cancer, according to a new ...

A cancer expert has shared the five types of cancer which are considered the most "lethal", and claimed people diagnosed with ...

In a new study published in the British Journal of Surgery, researchers describe successful tumor removal through the use of immunotherapy and targeted radiation therapy (TARE), in a patient ...

UDCA improved T cell function, promoting the recruitment of immune cells to the liver. Dietary supplementation of UDCA was enough to control tumor growth in mice with liver cancer, offering an ...

These findings may shape the future of liver cancer treatment, demonstrating that reducing BAAT and increasing UDCA can control tumor growth and improve T cell and immunotherapy efficacy.

Preliminary phase 1/1b dose expansion results of the bifunctional EGFR/TGFβ inhibitor ficerafusp alfa (BCA101) with pembrolizumab in patients with squamous cell carcinoma of the anal canal. GOBLET ...

Researchers at the Terasaki Institute for Biomedical Innovation have developed an innovative delivery system that could significantly improve the effectiveness of peptide-based cancer vaccines, ...